Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation. | Cancers (Basel) | 2021 | 34572725 | PubTator, text mining | PubMed |
| The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. | Cells | 2021 | 34572067 | PubTator, text mining | PubMed |
| Roles of miR-432 and circ_0000418 in mediating the anti-depressant action of ADAR1. | Neurobiol Stress | 2021 | 34568523 | PubTator, text mining | PubMed |
| Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development. | Cell Rep | 2021 | 34525349 | PubTator, text mining | PubMed |
| Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. | Blood Adv | 2021 | 34525182 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
| A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity. | Front Cell Dev Biol | 2021 | 34513832 | PubTator, text mining | PubMed |
| High Expression of ROMO1 Aggravates the Malignancy of Hepatoblastoma. | J Oncol | 2021 | 34512752 | PubTator, text mining | PubMed |
| Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification. | Cancers (Basel) | 2021 | 34503173 | PubTator, text mining | PubMed |
| Circulating circRNA as biomarkers for dilated cardiomyopathy etiology. | J Mol Med (Berl) | 2021 | 34498126 | PubTator, text mining | PubMed |
| Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. | Oxid Med Cell Longev | 2021 | 34497681 | PubTator, text mining | PubMed |
| CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner. | Mol Cancer | 2021 | 34496888 | PubTator, text mining | PubMed |
| Overview of the molecular mechanisms contributing to the formation of cancer‑associated adipocytes (Review). | Mol Med Rep | 2021 | 34490479 | PubTator, text mining | PubMed |
| Research Progress on the Mechanism of Cochlear Hair Cell Regeneration. | Front Cell Neurosci | 2021 | 34489646 | PubTator, text mining | PubMed |
| Integrated analysis of Solute carrier family-2 members reveals SLC2A4 as an independent favorable prognostic biomarker for breast cancer. | Channels (Austin) | 2021 | 34488531 | PubTator, text mining | PubMed |
| Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics. | Mol Ther Methods Clin Dev | 2021 | 34485592 | PubTator, text mining | PubMed |
| Cancer testis antigens and genomic instability: More than immunology. | DNA Repair (Amst) | 2021 | 34481156 | PubTator, text mining | PubMed |
| Association Between LIN28A Gene Polymorphisms and Glioma Susceptibility in Chinese Children. | Cancer Control | 2021 | 34468231 | PubTator, text mining | PubMed |
| The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. | Cancer Metastasis Rev | 2021 | 34453639 | PubTator, text mining | PubMed |
| Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1. | Ann Clin Lab Sci | 2021 | 34452886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=37